Currently, the only approved treatment worldwide for PBA is NUEDEXTA® in the U.S. MTS-004, classified in China as a Category 2.2 improved new drug, introduces an innovative ODT formulation that ...
The patient’s eyes welled up as soon as Marvin O. Delgado Guay, MD, FAAHPM, asked the question.The patient — a man in his mid-60s with advanced cancer — had been in severe pain despite being on a high ...
Antelope Surgical Solutions, a clinical-stage theranostics biotechnology company pioneering the world's first fluorescent radioligand platform that helps physicians see and treat cancer with precision ...
Encompass Health Corp. today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on Jan. 15, 2026, to holders of record on Jan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback